September 2019 – Page 5 – Clinical Trial Results

Dr. Sergio Leonardi and Dr. Andrea Rubboli Present: ESC 2019 Wrap-Up in Italian

September 3, 2019

Disclosures: TBA

Dr. Stefan James and Dr. Jonas Oldgren Presents: ESC 2019 Wrap-Up from the Scandinavian Perspective

September 3, 2019

Disclosures: TBA

Dr. Stefanie Schuepke and Dr. Adam T. Phillips Discuss: ISAR-REACT 5 – Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome

September 3, 2019

Disclosures: TBA

Pr. Dr. Sigmund Silber Presents: ESC 2019 Wrap-Up in German

September 3, 2019

Disclosures: TBA

Dr. Philip E. Aylward and Dr. John Amerena Present: ESC 2019 Wrap-Up from the Perspective of the Pacific Rim

September 3, 2019

Disclosures: TBA

Dr. Freek Verheugt Presents: ESC 2019 Wrap-Up from the Perspective of the Netherlands

September 3, 2019

Disclosures: TBA

Dr. Pascal Vranckx and Dr. C. Michael Gibson Discuss: ENTRUST-AF PCI – Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients.

September 3, 2019

Disclosures: TBA

Dr. Satoshi Yasuda and Dr. Arzu Kalayci Discuss: AFIRE – Rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease

September 2, 2019

Disclosures: TBA

Dr. John J.P. Kastelein and Dr. C Michael Gibson Discuss: Why Are Patients Not Achieving the LDL Goals? – Sponsored by an independent educational grant from The Medicines Company

September 2, 2019

Sponsored by an independent educational grant from The Medicines Company

Dr. James Januzzi and Dr. C. Michael Gibson Discuss: Effects of Angiotensin Receptor/Neprilysin Inhibitor Therapy on NT-proBNP and Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction: Primary Results of the PROVE-HF Study

September 2, 2019

Disclosures: TBA